Freshly arrived at #CVPR2024 to present our works on representation learning for pathology! 🤗 😎 Tomorrow will be a busy day with an Oral talk and 3 posters! Details below 👇 June 20th Thursday - TANGLE (Oral): Multimodal slide representation learning with Lukas Oldenburg (Main conference @ Summit Flex Hall C, 9:00AM ~ 12:00 PM PST) - SurvPath: Multimodal modeling for survival prediction with Anurag Vaidya - PANTHER: Morphological prototyping for human tissue with Andrew H. Song and Richard J. Chen TANGLE: https://lnkd.in/eF69Y5Hh SurvPath: https://lnkd.in/dtK7_WCv PANTHER: https://lnkd.in/ej7xC5xr
Guillaume Jaume’s Post
More Relevant Posts
-
I am happy to share that our recent paper entitled " FEM thermal assessment of a 3-D irregular tumor with capillaries in magnetic nanoparticle hyperthermia via dissimilar injection points " is now available online in the journal of Computers in Biology and Medicine (IF=6.6). You can download it for free until May 03 using: https://lnkd.in/dkn62XGf In this study, simulation of magnetic nanoparticle hyperthermia is performed on a 3D tumor model constructed based on a CT image of a tumor. In the first step, magnetic nanoparticles are injected into two points of the tumor tissue with the same parameters. Results show that temperature profiles in the vicinity of the injection points are not similar due to the presence of blood capillaries. Therefore, the effects of using dissimilar injection parameters for the two injection points on the heating pattern and damage fraction of the tumor are investigated. The results demonstrate that using dissimilar values for injection parameters such as injection rate, injection time, and nanofluid volume fraction is a way to achieve a higher damage fraction of the tumor cells, but, the asynchronous injections strategy does not lead to more significant damage to the tumor. None of the cases showed significant improvement in the uniformity of the temperature distribution, suggesting that conducting injections under the same conditions is the best way to create an almost uniform temperature profile. The numerical simulation validation results also advocate the accuracy of the model used in this study. This research can serve as a guide for designing parameters for future studies. #cancertreatment #hyperthermia #Magneticnanoparticles
LinkedIn
lnkd.in
To view or add a comment, sign in
-
Starts in 30 minutes!
⭐ WEBINAR TODAY - Register now!⭐ Don't miss our webinar today with the fantastic Carlo Bifulco, exploring in situ spatial interactomics and discovering how they can give us deeper insights into the tumor microenvironment 🔬 🗓️ Date: Tuesday 26 March 🕰️ Time: 15:00 GMT / 16:00 CET / 11:00 EST / 08:00 PST 💻 Registration: FREE! Speakers: Dr. Doroteya Raykova, Application Scientist at Navinci Diagnostics Dr. Carlo Bifulco, Chief Medical Officer at Providence Genomics Register here: https://lnkd.in/einRgYF6 Can't make it? Register anyway and get the recording after! #InSituProximityLigation #ProteinProteinInteractions #SpatialInteractomics #SpatialProteomics #SpatialBiology #Webinar
LinkedIn
lnkd.in
To view or add a comment, sign in
-
Answers - Medical Discovery News Quiz 14 Do you keep up with the latest science news? Check your science news prowess below. (5 correct –Nobel level; 4 correct – National Academy; 3 you are a Dean; 2 correct – Scientist; 1 correct, Back to Grad School! ). Answers revealed next week! For our podcast episodes go to: https://lnkd.in/gc-8-DGV ANSWERS! 1. SAT scores for US takers dropped to a new low for 2018-2022. US rankings compared to international takers are now: A) 6th in reading, B) 10th in science C) 26th in math 2. The are concerns for polar bears because of the changing climate. A new method for tracking individual bears involves: A) DNA recovered from paw prints in snow tracks 3. Recent research suggests that future visits to your ophthalmologist and a 3D eye scan may allow diagnosis and early monitoring of: A) kidney disease 4. FDA is investigating the identified risk of T cell malignancy after what promising cancer treatment: A) CAR-T therapy 5) A new tool to fight gonorrhea was recommended by a UK Joint Commission which was: A) the meningitis vaccine
LinkedIn
lnkd.in
To view or add a comment, sign in
-
DID YOU KNOW? Fact: AI is already being used to diagnose diseases. In fact, there are a number of AI-powered medical devices and applications that are currently being used to diagnose diseases, including: IBM Watson for Oncology: This AI-powered system can help doctors diagnose cancer more accurately and faster than ever before. Google DeepMind Health: This AI-powered system is being used to develop new treatments for diabetes and other chronic diseases. Enlitic: This AI-powered system is being used to detect cancer in medical images more accurately than human radiologists. https://lnkd.in/dQ-6bWw9 #socialmediamanagement #contentwriting #digitalmarketingagency #digitalmarketing #marketing #branding #videography #designing #marketingstrategy #advertising #graphicdesigning
LinkedIn
lnkd.in
To view or add a comment, sign in
-
The first cellular map of a mammalian brain has arrived. 🧠✨ Recently in a set of 10 papers in Nature, a network of researchers unveiled an atlas cataloging the location and type of every cell in the adult mouse brain. Over 6 years and 32 million cells in the making, it reveals astonishing diversity and regional specificity. Dive deeper: https://lnkd.in/gJKBFgpc This research is supported by The National Institutes of Health as part of the BRAIN Initiative Cell Census Network (BICCN). The mission of #BICCN is to provide a comprehensive reference of the diverse cell types in human, mouse, and non-human primate brain. #studyBRAIN
Scientists unveil first complete cellular map of adult mouse brain
lnkd.in
To view or add a comment, sign in
-
AI is reshaping so much of our lives - and clinical trials are no exception! Want to find out more about how is AI reshaping medical imaging? Curious about the next big thing in UI accessibility? Ready to discover the latest tech elevating patient safety? Secure your spot today in Clario's three-part webinar series exploring efficacy, safety and quality of life in oncology trial programs: https://lnkd.in/eQ99wju6 PART 1: Nov 28, 11am–12pm ET: Revolutionizing Oncology Clinical Trials: The Transformative Power and Promise of AI-Enhanced Medical Imaging PART 2: Dec 4, 11am–12pm ET: Using Scientific Validation to Move the Needle on Accessibility Functionalities PART 3: Dec 13, 11am–12pm ET: Integrating Objectively Measured Safety Endpoints and Patient-Reported Outcomes in Oncology Trials: A Scientific Approach For detailed info on the webinars, topics and speakers, visit clario.com.
LinkedIn
clario.shp.so
To view or add a comment, sign in
-
We have posted a new article on our Forensic News page! This article entitled: "Acceptability of post-mortem imaging among Muslim and non-Muslim communities" comes from the British Journal of Radiology. The article can be found here: https://lnkd.in/dPDrWZXA. We handpick and post a new article every week, so like and follow our page to see the latest articles and stay up to date! #journal
LinkedIn
lnkd.in
To view or add a comment, sign in
-
Say goodbye to manual radiology follow-up management forever! Inflo Health provides an AI-driven, intelligent technology and automated communication workflows to ensure radiology follow-ups are never missed. This results in the highest level of patient care, increased revenue, and decreased patient safety risk without adding additional staff. Check out our video now to discover the transformative power of Inflo Health. #healthtech #radiology #healthcareinnovation Watch here: https://lnkd.in/eFk4dVfN 😉
LinkedIn
lnkd.in
To view or add a comment, sign in
-
🚀 Are you in search of a specialized company that excels in SaMD data and product engineering? Look no further! Our team has been deeply immersed in several exciting projects within the fields of cardiology and neurology. 🧠❤️ ✨ Some of our recent accomplishments include: 🔵 Creation of a neuromodulation device tailored for mood disorders. 🔵 Design of a mobile application centered on ADHD management. 🔵 Development of a Class II ECG device for Holter and active patient monitoring. ... and numerous other innovative initiatives. Paying close attention to regulatory compliance, ensuring that the device meets the applicable FDA regulations and standards. We're passionate about turning visionary ideas into reality. Let's have a conversation about your project needs. 🤝 📩 Reach out to us at kumark@nu10.co for intriguing case studies and references, or... 🗓️ Schedule a no-obligation call here: https://lnkd.in/gP35xv6D to explore how Nu10 can help you achieve your goals. 📆 Let's collaborate and make a difference together! 🌟 #SaMD #Engineering #Innovation #HealthTech #ProductDevelopment #Cardiology #Neurology #HealthcareTech
LinkedIn
lnkd.in
To view or add a comment, sign in
Postdoctoral research fellow in Computational Pathology
3wSo excited for you 😀